Event details

In September 2023, the NHS waiting list reached a record high of 7,771,057, consisting of around 6,499,151 individual patients waiting for treatment in England.

It will take years to clear the backlog. The ongoing need for stringent infection prevention control measures and workforce shortages mean it will take even longer to work through as demand continues to rise. This backlog has been a significant concern, exacerbated by the COVID-19 pandemic, which led to resource reallocation and disruptions across healthcare services. The backlog has resulted in longer waiting times for patients seeking various medical interventions, increasing the pressure on the NHS.

Join us at our NHS Backlog event to discover valuable, actionable insights and strategies for managing and reducing the backlog challenges currently faced by the NHS.

 


 
   

Want to sponsor

 

Want to speak









WHO ATTENDS

  • Available On Demand

    Keynote

    Dr. Austen El-Osta, Director, Self-Care Academic Research Unite(SCARU), Imperial College London


    Dr. Austen El-Osta
    Dr. Austen El-Osta Director, Self-Care Academic Research Unite(SCARU) Imperial College London

    I am the Director of the Self-Care Academic Research Unit (SCARU) & Primary Care Research Manager at the School of Public Health. I'm also supporting the WHO Collaborating Centre for Public Health Education and Training, NIHR Diagnostic Evidence Co-operative London, West London Research Network (WeLReN), Imperial Research Hub and Imperial College Healthcare NHS Trust (ICHT) Directorate of Public Health & Primary Care in the same capacity.


    My principal aim is to widen access & participation in research and to help accelerate the widespread adoption & diffusion of evidence-based health and well-being interventions.


    Prior to assuming this role, I was based at Guy’s Hospital where I worked in a similar capacity within the NIHR Clinical Research Network. My earlier career spanned a number of disparate fields including molecular & cell biology, vision research, laser-tissue interaction & medical device engineering.

  • Available On Demand

    Diagnostics

    This panel addresses the critical realm of diagnostics, envisioning a future characterised by patient empowerment and technology-driven self-management. With a focus on practical and efficient implementation of new technologies, we look at the future of diagnostics and what can be done quickly to minimise the backlog and reduce waiting lists.


    By modernising diagnostic practices and being open to implementing new technologies, we can ensure a new, more streamlined approach to delivering patient-centric healthcare.


    Matt Inada-Kim
    Matt Inada-Kim Consultant Acute Physician Hampshire Hospitals NHS Foundation Trust

    Matt is a consultant acute physician and visiting professor at Hampshire Hospitals and the University of Southampton and Clinical Director for Digital Innovation at Wessex AHSN.

    His roles at NHS England are as National Clinical Director for Infection Management, AMR and Deterioration; National speciality advisor for sepsis, National clinical lead for COVID pathways/oximetry@home/virtual wards and the Deterioration and Sepsis CQUINs.


    He has led the development of a standardised national methodology for assessing the burden of infections and sepsis, their outcomes and improvement.


    He co-developed and co-led the implementation of NEWS2 across all hospitals and ambulance trusts nationally, and the deterioration CQUIN that has been implemented across 114 acute trusts and represents a global first in incentivising the optimal management of acutely ill patients most at risk of death.


    He co-developed/led on national sepsis, deterioration and COVID clinical pathways in all community/interface settings, developing and then publishing evidence on the home oximetry monitoring strategy (through leading a national community of practice and clinical reference groups) that led to the purchase of 1.2 million oximeters and national implementation within 38 days and across a further 18 countries during the pandemic.


    He is currently developing community-based, acute respiratory infection assessment hubs, having published papers demonstrating their effectiveness as integrated care models supporting urgent care and primary care transformation. 363 were set up last winter, seeing over 740,000 patients in 4 months.


    HSJ award winner in Sepsis 2019, Deterioration 2020 and Patient Safety 2021

    Elaine Gilliland
    Elaine Gilliland Program Director Dudley Group NHS Foundation Trust
    Transformation Lead, Innovator, Strategist, Chair, CEO
    Helen Hoyland
    Helen Hoyland Head of Commercial Innovation and Growth Health Innovation Yorkshire and Humber

    Helen is from Health Innovation Network Yorkshire and Humber  where she is responsible for developing and sustaining strategic partnerships with NHS leaders, academia, large industry, national and regional scientific and academic bodies and collaborative programmes, such as digital transformation and service redesign. These relationships translate into collaborative large scale innovation programmes, collaborative multi agency funding awards for research and innovation and inform place based and regional digital and innovation strategies across three Integrated Care Systems. Helen leads a team who  support SMEs and innovators and NHS organisations to support rapid testing, adoption and scale of innovations. The HIN  has three flagship accelerator programmes including Propel@ YH and Digital North.

    Prior to joining the HIN,  Helen was Strategic Engagement lead for Nutricia Medical, part of the Danone Group, and national programme lead for Research and Innovation at NHS England

     

    Julie Hart
    Julie Hart Diagnostics Pathway Transformation Specialist Oxford University Hospitals NHS Foundation Trust
    Julie has more than 30 years’ experience of the diagnostics industry and almost 10 years' experience in generating evidence and accelerating the adoption of diagnostics and artificial intelligence solutions into the National Health Service (NHS). Julie is co-investigator for UK and EU grant funded projects focused on developing the value proposition for healthcare adoption by generating evidence of clinical needs in care pathways and writing strategies for NHS adoption. As well as being a co-investigator, Julie provides a "second set" of eyes review for innovators applying for grant funding through the National Institute of Health and Social Care Research (NIHR).
  • Available On Demand

    Digital Infrastructure

    In this session we focus on the transformative potential of digital healthcare technology. We will highlight the possibilities that come with the creation of a scalable digital care ecosystem, how that can accelerate the delivery of patient care, improve it, and effectively reduce the backlog.


    Digital technologies will pave the way for enhanced healthcare delivery, form the foundations of creating more scalable operations, and play a critical role in the achievement of the broader goal – ensuring accessible and impactful patient care for all.

     


    Matt Inada-Kim
    Matt Inada-Kim Consultant Acute Physician Hampshire Hospitals NHS Foundation Trust

    Matt is a consultant acute physician and visiting professor at Hampshire Hospitals and the University of Southampton and Clinical Director for Digital Innovation at Wessex AHSN.

    His roles at NHS England are as National Clinical Director for Infection Management, AMR and Deterioration; National speciality advisor for sepsis, National clinical lead for COVID pathways/oximetry@home/virtual wards and the Deterioration and Sepsis CQUINs.


    He has led the development of a standardised national methodology for assessing the burden of infections and sepsis, their outcomes and improvement.


    He co-developed and co-led the implementation of NEWS2 across all hospitals and ambulance trusts nationally, and the deterioration CQUIN that has been implemented across 114 acute trusts and represents a global first in incentivising the optimal management of acutely ill patients most at risk of death.


    He co-developed/led on national sepsis, deterioration and COVID clinical pathways in all community/interface settings, developing and then publishing evidence on the home oximetry monitoring strategy (through leading a national community of practice and clinical reference groups) that led to the purchase of 1.2 million oximeters and national implementation within 38 days and across a further 18 countries during the pandemic.


    He is currently developing community-based, acute respiratory infection assessment hubs, having published papers demonstrating their effectiveness as integrated care models supporting urgent care and primary care transformation. 363 were set up last winter, seeing over 740,000 patients in 4 months.


    HSJ award winner in Sepsis 2019, Deterioration 2020 and Patient Safety 2021

    Tom Fish
    Tom Fish Specialist Radiotheraphy Practitioner for IM&T Royal Berkshire NHS Foundation Trust
    Passionate about patient-centred digital transformation, I have a background as a Therapeutic Radiographer, blending advanced clinical expertise with exceptional IT skills. With a proven track record in leading transformative projects, I thrive on driving efficiency and improving patient care.
    Karl Redmond
    Karl Redmond Smart Buildings Architect NHP
    I am a Strategic Estates Lead, NHS Estates Delivery Unit and on Secondment to the New Hospital Programme, ICS Estates Infrastructure Guidance, developing Digital Smart Buildings (New and Existing NHS estate programmes). I'm engaged in strategic Estates and Facilities requirements across the NHS (Primary, Acute & Mental Health), whilst also developing digital smart building guidance capturing; sustainability, EFM asset management, asset tracking and much more. My function, as part of the Digital Smart Building programmes, relate to, new builds and legacy estate plans, driving the necessary links, improving processes and practices to produce tangible and measurable outputs during the capital build phase, which are fed into the operational phase for continuous improvement opportunities during the assets life. I target critical areas of estates and facilities programme, linked to clinical and non-clinical environments and identify realisable monetary and non-monetary (e.g. patient) benefits.

    I am a member of UK Digital Estates Group, a Fellow of the Leeds Sustainability Institute and continuously advancing my knowledge of the built environment, specifically Asset & Process Digitisation; Smart Enterprise Asset Management solutions; FM & Estates strategies. Working with numerous UK academic institutions, industry bodies, standards groups and WHO.

    I have won, developed and maintained multi-million pound projects and portfolios in public and private sectors. Self motivated with the ability to engage at all levels of business, Government, corporate and supply chains. I have delivered international Healthcare and Digital Real Estate ecosystem conference talks in Dubai, Lisbon, Hamburg, Stockholm and across the UK. I have studied and had published a number of academic papers and articles, regarding negotiation & influencing; real estate strategies; digital asset management & sustainability; healthcare estates & patient flows; digital innovation & transformation strategies and IoT projects.

    I have business, corporate and real estate experience ranging from strategic planning, optimisation & utilisation and finance, along with, commercial and strategic understanding of IT, procurement, R&D programmes, project management, facilities & estate management, asset assessment & improvement programs, IoT projects, integrated data systems, all aimed at delivering client requirements, RoI, whilst maximising and capitalising on new opportunities
  • Available On Demand

    Patient Flow

    This panel discussion will centre around the importance of finding solutions to improve patient flow and make it more efficient. If NHS organisations can find ways to move patients from one care setting to another or between departments without delays between each pathway, the backlog will naturally reduce.


    A key aspect of this discussion will centre around improving communication channels between healthcare professionals and patients to foster a more collaborative all-round approach to healthcare delivery. This will improve overall patient outcomes, effectively cut waiting lists, and improve the quality and accessibility of healthcare services.

     


    Jody Blow
    Jody Blow ACP - Trauma & Orthopaedics United Lincolnshire NHS Hospital Trust
    Advanced Clinical Practitioner (ACP) in trauma and orthopaedics with a demonstrated history of working in the hospital & health care industry. Skilled in Clinical Research, Patient Safety, Acute Care, Nursing, and peri operative care. Strong healthcare services professional with a Master of Science (MSc) focused in Advanced Clinical Practice from Univesity of nottingham.
    Maria Picciochi
    Maria Picciochi Clinical Research Fellow, Global Surgery Unit University of Birmingham
    PhD student & General surgery trainee

    Currently a PhD student and clinical research fellow at the University of Birmingham - NIHR Global Surgery Unit. I started my surgical training in Portugal (Jan 2021).

    Collaborative research enthusiast (PTSurg, CovidSurg, GlobalSurg) with teamwork expertise and improving leadership skills. Special interest in global surgery, surgical systems, optimisation and management of elective care and elective surgery.

    I am trying to bridge gaps between academia and clinical practice, to improve patient care.
    Robert Salter
    Robert Salter Consultant Innovation Scientist Cwm Taf Morgannwg University Health Board
    Kaya M Dreesbeimdiek
    Kaya M Dreesbeimdiek Phd Candidate (Healthcare Operations Management) at Department of Engineering University of Cambridge

    Kaya is an industrial engineer and doctoral researcher at the University of Cambridge. Her work focusses on strategies to enable the resilient delivery of emergency department services.

  • Available On Demand

    Keynote

    Carol Munt, Patient Partner & Advocate, NHS England

    Carol Munt
    Carol Munt Patient Partner & Advocate NHS England
    Lived Experience Partner, Advocate, Public speaker
    Doubleday Affiliate Manchester School
    NHS England Experience of Care Team - Co-Production
    NHS Leadership Academy Experience of Care partner,
    National Steering Group: Maximising Leadership Learning in the Pre-Registration Healthcare Curricula
    HQIP Service User Network,
    Q community,
    Beryl Institute Global Experience Measuring Team

    Previous experience
    Co-Chair NHS Thames Valley Patient Experience Operation Group and member of,
    NHS Thames Valley SCN Oversight Group,
    Health Education England Thames Valley Partnership Council,
    Oxford AHSN Clinical Innovation Adoption Group & Oversight Group
    National AHSN Network of Networks.
    Physician Associate Joint Project Team (University of Reading),
    Reading Borough Council Carers Group.
    Dementia Handbook for Carers and Care Providers editorial team
  • Available On Demand

    Transformational Technology

    This insightful discussion will explore new innovations in healthcare technology that could transform healthcare operations and help minimise the backlog. We will consider the Elective Recovery Plan, which outlines the NHS’ approach to deploying cutting-edge initiatives, including 95 surgical hubs, 135 community diagnostic centres, and enhanced preoperative preparations to accelerate patient recovery times.


    We will also consider how artificial intelligence (AI) will continue to become a key component of new solutions and how this will streamline processes to reduce the backlog over time. This exploratory, thought-provoking session is sure to provide fresh insight and spark new ideas for NHS leaders and healthcare providers across every setting.


    Penny Kechagioglou
    Penny Kechagioglou Chief Clinical Information Officer and Deputy Chief Medical Officer University Hospitals Coventry and Warwickshire (UHCW) NHS Trust
    As a senior Oncology physician, Clinical and Medical director, I bring extensive experience and a diverse portfolio of Strategic Planning, Organisational Leadership, Clinical and Corporate Governance, Digital Transformation, Research and Innovation strategy, to support healthcare organisations to realise and manage change.

    Leveraging my experience in the public, private and charitable healthcare sectors, I possess a unique understanding of the relationship between those entities and how they interact in an Integrated Care System, in order to achieve shared purpose and societal benefits.

    My research work and interest is in Innovation processes and Leadership enablers within healthcare organisations. Individual, organisational and system leadership behaviours have a profound effect on the success of Innovation adoption and diffusion within Integrated Care Systems. This work inspired me to train further as a Coach with specialism in Health and Wellbeing, Positive Psychology and Functional Medicine, with a vision to support people and organisations to achieve their goals and be the best they can possibly be.
    Rowan Pritchard-Jones
    Rowan Pritchard-Jones Executive Medical Director Cheshire & Merseyside ICS NHS Cheshire & Merseyside

    Professor Rowan Pritchard Jones is a Consultant Plastic Reconstructive Surgeon at Mersey and West Lancs NHS Teaching Hospital Trust.  He is an Honorary Clinical Professor at both University of Liverpool and Edge Hill University, with an academic interest in skin cancer and chemo resistance as well as population health. He has national roles, leading in research for the British Association of Plastic Reconstructive and Aesthetic Surgeon (BAPRAS) as well as leading in skin cancer for the National Cancer Research Institute (NCRI) and plastic and hand surgery for NIHR North West Coast.


    Rowan was appointed as Executive Medical Director to the Cheshire and Merseyside Integrated Care System in July 2022.  Rowan is committed to system wide improvements for patients and is determined to break down the silos of working that have been a barrier to truly joined up healthcare across social, primary, secondary and tertiary care.  Rowan is also a committed collaborator with a passion for innovative solutions in a post-pandemic NHS.

    Helen Hoyland
    Helen Hoyland Head of Commercial Innovation and Growth Health Innovation Yorkshire and Humber

    Helen is from Health Innovation Network Yorkshire and Humber  where she is responsible for developing and sustaining strategic partnerships with NHS leaders, academia, large industry, national and regional scientific and academic bodies and collaborative programmes, such as digital transformation and service redesign. These relationships translate into collaborative large scale innovation programmes, collaborative multi agency funding awards for research and innovation and inform place based and regional digital and innovation strategies across three Integrated Care Systems. Helen leads a team who  support SMEs and innovators and NHS organisations to support rapid testing, adoption and scale of innovations. The HIN  has three flagship accelerator programmes including Propel@ YH and Digital North.

    Prior to joining the HIN,  Helen was Strategic Engagement lead for Nutricia Medical, part of the Danone Group, and national programme lead for Research and Innovation at NHS England

     

Register

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy. * Required Fields